Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2008, for PowerVerde, Inc. (formerly Vyrex Corporation). The company is classified as a development-stage entity. On February 12, 2008, the company completed a reverse acquisition merger with PowerVerde Systems, Inc., shifting its focus from a defunct biotech business to the development of patented renewable power systems. As of August 18, 2008, there were 25,882,878 shares of common stock outstanding.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2008 | Six Months Ended June 30, 2007 |
|---|---|---|
| Revenue (Licensing and Royalty) | $14,299 | $0 |
| Net Loss | $(291,435) | $(15,672) |
| Cash and Cash Equivalents (End of Period) | $18,711 | $20,943 |
| Total Assets | $32,105 | $405,200 |
| Total Liabilities | $123,009 | $0 |
| Working Capital | $(101,061) | $393,713 |
| Accumulated Deficit | $(13,859,039) | $(274,402) |
Debt and Liquidity: The company holds $72,500 in Series A Promissory Notes payable as of June 30, 2008, bearing 10% annual interest. The company reported a cash burn of $240,243 from operating activities for the six-month period.
Material Changes vs. Prior Period
- Revenue: The company generated $14,299 in revenue for the six months ended June 30, 2008, compared to zero in the prior year. This revenue stems from a minimum royalty payment under a Boron compound sublicense agreement.
- Expenses: Operating expenses surged to $312,467 for the six months ended June 30, 2008, compared to $15,672 in the prior year. This increase is primarily attributed to the integration of PowerVerde operations and increased research and development (R&D) costs.
- Balance Sheet: Total assets decreased significantly from $405,200 to $32,105. This reduction reflects the accounting treatment of the reverse acquisition, where the historical assets of the predecessor (Vyrex) were largely eliminated or reclassified, and the company now operates with minimal cash and receivables.
- Liabilities: Current liabilities increased from zero to $123,009, driven by new notes payable ($72,500) and accounts payable ($50,509).
Outlook, Risks, and Management Commentary
- Plan of Operation: The company intends to mass-produce patented renewable power systems using an outsourcing model with Arizona Research and Development (ARD). Beta testing is expected to conclude by the end of the third quarter of 2008.
- Capital Needs: Management explicitly states the need to raise substantial additional capital to finance operations. If funds cannot be raised timely, the company may be forced to cease operations.
- Financing Activity: The company completed an offering of $250,000 in Series A Promissory Notes. $72,500 was received by June 30, 2008, with the remainder expected in the third quarter. Investors received warrants to purchase common stock at $1.50 per share.
- Risks: The company has no employees as of the report date and has not entered into distribution or marketing agreements. There is no assurance that beta testing will succeed or that future financing will be available.
Investor Verification Checklist
- Verify the status of the $177,500 remaining balance of the Series A Promissory Notes offering and whether it was successfully raised in Q3 2008.
- Confirm the completion of beta testing for the renewable power systems and the timeline for commercial production.
- Assess the company's ability to generate revenue beyond the minimal $7,500 annual royalty, given the lack of product sales history.
- Review the terms of the manufacturing agreement with Arizona Research and Development (ARD) to ensure fair market pricing and capacity.
- Monitor cash burn rates against the current cash balance of $18,711 to determine the runway before additional financing is critical.